Title:
FUSED RING COMPOUND HAVING GLP-1 RECEPTOR AGONIST EFFECT
Document Type and Number:
WIPO Patent Application WO/2024/063143
Kind Code:
A1
Abstract:
The present invention relates to a compound represented by formula (I) or (II) or a pharmaceutically acceptable salt thereof. Formula (I): [wherein: A1 is C(R1), etc.; R1 is a hydrogen atom, etc.; R8 is a hydrogen atom, etc.; B1 is CH, etc.; R10 is cyano, etc. R3 is a phenyl group optionally substituted with a group of substituents F, etc.; the group of substituents F: halogen, cyano, alkyl, haloalkyl, alkyloxy and haloalkyloxy; Q is a substituted or unsubstituted benzene ring, etc.; R2 is a substituted or unsubstituted alkyl, etc.; and -L- is a group represented by the formula, etc.].
Inventors:
KITAMURA FUJIWARA MISATO (JP)
NISHIURA YUJI (JP)
MAENO SHOMITSU (JP)
KUSANO HIROKI (JP)
WADA TOSHIHIRO (JP)
NISHIURA YUJI (JP)
MAENO SHOMITSU (JP)
KUSANO HIROKI (JP)
WADA TOSHIHIRO (JP)
Application Number:
PCT/JP2023/034298
Publication Date:
March 28, 2024
Filing Date:
September 21, 2023
Export Citation:
Assignee:
SHIONOGI & CO (JP)
International Classes:
C07D405/06; A61K31/4184; A61K31/4355; A61K31/4375; A61K31/4725; A61K31/4741; A61K31/498; A61K31/4985; A61K31/519; A61P3/04; A61P3/10; A61P43/00; C07D405/14; C07D471/04; C07D491/056; C07D519/00
Domestic Patent References:
| WO2021244645A1 | 2021-12-09 | |||
| WO2021219019A1 | 2021-11-04 | |||
| WO2021197464A1 | 2021-10-07 | |||
| WO2023138684A1 | 2023-07-27 | |||
| WO2023179542A1 | 2023-09-28 |
Foreign References:
| JP2021521265A | 2021-08-26 | |||
| CN115594669A | 2023-01-13 |
Attorney, Agent or Firm:
YAMAO, Norihito et al. (JP)
Download PDF: